Literature DB >> 27373321

The role of the inflammasome in patients with autoinflammatory diseases.

Hal M Hoffman1, Lori Broderick2.   

Abstract

Autoinflammatory diseases are disorders of the innate immune system, characterized by systemic inflammation often driven by inflammasomes, and independent of infection and autoreactive antibodies or antigen-specific T cells. These diseases are increasingly recognized as disorders of immune dysregulation, presenting with a constellation of fevers, rashes, and mucosal symptoms in many cases, which suggests that the allergist/immunologist is the appropriate specialist for these patients. However, many practicing physicians are unaware of these disorders in their pediatric and adult patient populations, leading to substantial delays in diagnosis. Recognizing autoinflammatory disease symptom patterns, performing appropriate diagnostic tests, and instituting early effective therapy are essential to reduce morbidity and mortality in these patients. This review will focus on understanding the molecular basis of inflammasomes, recognizing the distinguishing features of the classic autoinflammatory disorders, and appreciating the treatment modalities available.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoinflammation; inflammasome; innate immunity

Mesh:

Substances:

Year:  2016        PMID: 27373321     DOI: 10.1016/j.jaci.2016.05.001

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  28 in total

Review 1.  Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease.

Authors:  Holly Anderton; Ian P Wicks; John Silke
Journal:  Nat Rev Rheumatol       Date:  2020-07-08       Impact factor: 20.543

2.  JAK inhibitors in autoinflammation.

Authors:  Hal M Hoffman; Lori Broderick
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

Review 3.  Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach.

Authors:  Peter A Nigrovic; Pui Y Lee; Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2020-11       Impact factor: 10.793

4.  Editorial: It Just Takes One: Somatic Mosaicism in Autoinflammatory Disease.

Authors:  Hal M Hoffman; Lori Broderick
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

5.  Patients with tumour necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) are hypersensitive to Toll-like receptor 9 stimulation.

Authors:  O H Negm; S Singh; W Abduljabbar; M R Hamed; P Radford; E M McDermott; E Drewe; L Fairclough; I Todd; P J Tighe
Journal:  Clin Exp Immunol       Date:  2019-05-22       Impact factor: 4.330

6.  Nlrp3 inflammasome activation in macrophages suffices for inducing autoinflammation in mice.

Authors:  Ulrika C Frising; Silvia Ribo; M Giulia Doglio; Bernard Malissen; Geert van Loo; Andy Wullaert
Journal:  EMBO Rep       Date:  2022-05-16       Impact factor: 9.071

7.  NLRP3 inflammasome-mediated choroid plexus hypersecretion contributes to hydrocephalus after intraventricular hemorrhage via phosphorylated NKCC1 channels.

Authors:  Zhaoqi Zhang; Qiang Tan; Peiwen Guo; Suna Huang; Zhengcai Jia; Xin Liu; Hua Feng; Yujie Chen
Journal:  J Neuroinflammation       Date:  2022-06-21       Impact factor: 9.587

Review 8.  Inflammatory osteolysis: a conspiracy against bone.

Authors:  Gabriel Mbalaviele; Deborah V Novack; Georg Schett; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

Review 9.  Inflammasomes and the fine line between defense and disease.

Authors:  Shelbi Christgen; Thirumala-Devi Kanneganti
Journal:  Curr Opin Immunol       Date:  2019-12-25       Impact factor: 7.486

10.  Development of a Validated Interferon Score Using NanoString Technology.

Authors:  Hanna Kim; Adriana A de Jesus; Stephen R Brooks; Yin Liu; Yan Huang; Rachel VanTries; Gina A Montealegre Sanchez; Yaron Rotman; Massimo Gadina; Raphaela Goldbach-Mansky
Journal:  J Interferon Cytokine Res       Date:  2018-04       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.